IGMS: IGM Biosciences Inc Company Profile & Statistics

About

IGM Biosciences Inc. is a biotechnology company. It engages in the research and development of engineered Immunoglobulin M antibodies for the treatment of cancer patients. The company's lead product candidate is IGM-2323, a bispecific T cell engaging IgM, which are in clinical stage. IGM Biosciences Inc. is based in Mountain View, California.

Info & Links

CEO

Fred Schwarzer

Headquarters

325 EAST MIDDLEFIELD ROAD
MOUNTAIN VIEW, CA 94043, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

224

IGM Biosciences Inc Statistics

Valuation Measures

Market Capitalization²

444.76M

Enterprise Value

401.70M

Enterprise Value/EBITDA(ttm)

-1.72

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

146.11

Price to Book(mrq)

5.40

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-7534.03%

Profit Margin(ttm)

-8767.92%

Return on Equity(ttm)

-155.42%

Return on Invested Capital(ttm)

-177.72%

Return on Assets(ttm)

-61.04%

Income Statement

Revenue(ttm)

2.92M

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

2.92M

EBITDA(ttm)³

-233.47M

Net Income Available to Common(ttm)

-219.84M

Diluted EPS(ttm)

-3.64

Share Statistics

Beta (5Y Monthly)

0.08

52-Week Change

26.99%

S&P 500 52-Week Change

28.02%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

59.46M

Dividend Yield

0.00%

Float⁴

25.57M

% Held by Insiders

57.00%

% Held by Institutions

42.79%

Balance Sheet

Total Cash(mrq)

218.98M

Total Cash Per Share(mrq)

3.68

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.22%

Quick Ratio(mrq)

5.22%

Book Value Per Share(mrq)

1.33

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.95

Free Cash Flow(ytd)

-123.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IGMS

IGM Biosciences Inc

IGM Biosciences Inc Profile